Drug Delivery Systems Market to Reach US$ 2,302.2 Bn at CAGR of 7.2% in 2027 | The Insight Partners

Drug Delivery Systems Market to 2027- Global Analysis and Forecasts by Route of Administration (Oral, Transmucosal, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); Application (Hospitals & Clinics, Home Care Settings, and Others) and Geography

Publication Month: May 2019 | Report Code: TIPHE100000854 | No. of Pages: 343 | Category: Medical Device | Status: Published

The global drug delivery systems market accounted to US$ 1,243.1 Bn in 2018 and is expected to grow at a CAGR of 7.2% during the forecast period 2019 – 2027, to account to US$ 2,302.2 Bn by 2027.

Asia Pacific is the fastest growing geographic market and it is expected to be the second largest revenue contributor throughout the forecast period. The growth is contributed majorly by driving factors such as significant rise in the prevalence of chronic diseases across the countries, rise in the government support for the patient population. In addition, the market players are also developing novel products in the countries through robust R&D activities and partnerships and acquisitions.

Exhibit: Lucrative Regional Markets

Market Insights
Rising Incidence of Chronic Diseases
Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to increasing prevalence of chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in the 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases.
Some important technological advantages of nanotherapeutic drug delivery systems (NDDS) include prolonged half-life, improved bio-distribution, increased circulation time of the drug, controlled and sustained release of the drug, versatility of route of administration, increased intercellular concentration of drug and many more.

Growing Demand for Non Invasive Drug Delivery Devices
With the improvements in medical devices and certain transdermal delivery technologies, the non-invasive mode of drug delivery is now ready to compete with traditional methods of oral and injectible routes of drug delivery. The Non-Invasive Drug Delivery Systems encompasses the broad field of non-invasive drug delivery systems which includes drug delivery via topical, transdermal-active (device- aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, as well as delivery via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery and therefore these techniques are considered to be a preferred mode of drug delivery.

Product Insights
The global drug delivery systems market by product segments was led by oral drug delivery segment. In 2018, the oral drug delivery segment held a largest market share of 50.2% of the drug delivery systems market, by route of administration. The transmucosal segment is expected to be the fastest growing segments the market in 2027 owing to rapidly rising incidence of chronic disorders, including gastrointestinal, respiratory, and autoimmune disorders.

Exhibit: Global drug delivery systems Market, by Route of Administration

Strategic Insights
Product launches and up gradation were observed as the most adopted strategy in global drug delivery systems industry. For instance, in January 2019, BD launched BD Nano 2nd gen pen needles reinforces BD’s commitment to providing the most advanced solutions possible for people with diabetes to help achieve better clinical management of insulin use. The developments performed by the companies are helping the market to grow in the coming years.

DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION

Global Drug Delivery Systems Market – By Route of Administration
  • Oral
    • Solid Oral Drugs
    • Liquid Oral Drugs
    • Semi-solid Oral Drugs
  • Transmucosal
    • Pulmonary Drug Delivery
      • In-metered Dose Inhalers
      • Dry Powder Inhaler
      • Nebulizers
    • Nasal Drug Delivery
      • Nasal Sprays
      • Nasal Drops
      • Nasal Gels
    • Buccal Drug Delivery
    • Sublingual Drug Delivery
    • Rectal Transmucosal Drug delivery
    • Vaginal Transmucosal Drug Delivery
  • Injectable
    • Conventional Injection Devices
    • Self-Injection Devices
      • Needle Free Injectors
      • Pen Injectors
      • Wearable Injectors
  • Topical
    • Semi-solid Topical Drug Delivery Formulations
    • Liquid Topical Drug Delivery Formulations
    • Solid Topical Drug Delivery Formulations
    • Transdermal Patches
    • Transdermal Gels
    • Others
  • Implantable
    • Active Implantable
    • Passive Implantable
  • Ocular
    • Eye Drops & Sprays
    • Gels & Ointments
    • Ocular Inserts
    • Drug Coated Contact Lenses
Global Drug Delivery Systems Market – By Application
  • Hospital & Clinics
  • Home Care Settings
  • Others
Global Drug Delivery Systems Market – By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global Drug Delivery Systems Market – By Geography
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
  • Middle East & Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
  • South & Central America (SCAM)
    • Brazil
Company Profiles
  • BD
  • Novo Nordisk A/S
  • 3M
  • Boston Scientific Corporation
  • Bausch Health Companies Inc.
  • Baxter International, Inc.,
  • Boehringer Ingelheim
  • Novartis AG
  • GlaxoSmithKline plc.
  • Johnson & Johnson Services, Inc.

1.             INTRODUCTION

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       market segmentation

1.3.1        Global Drug delivery systems market – By

1.3.2        Global Drug delivery systems market – By Application

1.3.3        Global Drug delivery systems market – By Distribution Channel

1.3.4        Global Drug delivery systems market – By Geography

2.             Global Drug delivery systems market –  Key takeaways

3.             research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Drug delivery systems– market landscape

4.1       overview

4.2       pest analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        South & Central America – PEST Analysis

5.             drug delivery systems market – Key Market Dyanamics

5.1       Key Market Drivers

5.1.1        Rising Incidence of Chronic Diseases

5.1.2        Growing Demand for Non Invasive Drug Delivery Devices

5.1.3        Increasing R&D Expenditures in Pharmaceutical And Medical Device Companies

5.2       Key Market Restraints

5.2.1        High Cost Involved In Development Of  Drug Delivery Devices

5.2.2        Product Recalls

5.3       Key Market Opportunities

5.3.1        Increasing Patient Compliance

5.4       Future Trends

5.4.1        Growing New Innovations In Drug Delivery Technology

5.5       Impact analysis

6.             drug delivery systems market – Global Analysis

6.1       global drug delivery systems market Revenue Forecasts and Analysis

6.2       global Drug delivery systems market, By Geography - Forecasts and Analysis

6.3       PERFORMANCE OF Prominent PLAYERS

6.3.1        BD

6.3.2        3M

6.3.3        GlaxoSmithKline plc.

6.3.4        Novartis AG

7.             drug Delivery systems Market –  global Regulatory Scenario

7.1       north america

7.1.1        US

7.1.2        Canada

7.1.3        Mexico

7.2       Europe

7.3       ASia Pacific

7.3.1        Japan

7.3.2        China

7.3.3        India

7.4       middle east & africa

7.4.1        Saudi Arabia

7.4.2        South Africa

7.5       South & Central America

7.5.1        Brazil

8.             drug delivery systems market Analysis and forecasts to 2027 – route of administration

8.1       Overview

8.2       Route of administration market Revenue and Forecasts Analysis (US$ Mn)

8.3       oral drug delivery Market

8.3.1        Overview

8.3.2        Oral Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

8.3.3        Solid Oral Drugs Market

8.3.3.1      Overview

8.3.3.2      Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)

8.3.3.3      SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.3.4        Liquid Oral Drugs  Market

8.3.4.1      Overview

8.3.4.2      Liquid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)

8.3.4.3      Liquid Oral Drugs MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.3.5        Semi-solid Oral Drugs  Market

8.3.5.1      Overview

8.3.5.2      Semi-Solid Oral Drugs Market Revenue and Forecast to 2027 (US$ Mn)

8.3.5.3      SEMI-SOLID ORAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4       transmucosal drug delivery Market

8.4.1        Overview

8.4.2        Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources

8.4.3        Pulmonary Drug Delivery Market

8.4.3.1      Overview

8.4.3.2      Pulmonary Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

8.4.3.3      PULMONARY DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.3.4      In-metered Dose Inhalers Market

8.4.3.4.1       Overview

8.4.3.4.2       In-metered Dose Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

8.4.3.4.3       IN-METERED DOSE INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.3.5      Dry Powder Inhalers Market

8.4.3.5.1       Overview

8.4.3.5.2       Dry Powder Inhalers Market Revenue and Forecast to 2027 (US$ Mn)

8.4.3.5.3       DRY POWDER INHALERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.3.6      Nebulizers Market

8.4.3.6.1       Overview

8.4.3.6.2       Nebulizers Market Revenue and Forecast to 2027 (US$ Mn)

8.4.3.6.3       NEBULIZERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.4        Nasal Drug Delivery Market

8.4.4.1      Overview

8.4.4.2      Nasal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

8.4.4.3      NASAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.4.4      Nasal Spray Market

8.4.4.4.1       Overview

8.4.4.4.2       Nasal Spray Market Revenue and Forecast to 2027 (US$ Mn)

8.4.4.4.3       NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.4.5      Nasal Drops Market

8.4.4.5.1       Overview

8.4.4.5.2       Nasal Drops  Market Revenue and Forecast to 2027 (US$ Mn)

8.4.4.5.3       NASAL SPRAY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.4.6      Nasal Gel Market

8.4.4.6.1       Overview

8.4.4.6.2       Nasal Gel  Market Revenue and Forecast to 2027 (US$ Mn)

8.4.4.6.3       NASAL GEL MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources

8.4.5        Buccal Drug Delivery Market

8.4.5.1      Overview

8.4.5.2      Buccal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

8.4.5.3      BUCCAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.6        Sublingual Drug Delivery Market

8.4.6.1      Overview

8.4.6.2      Sublingual Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

8.4.6.3      SUBLINGUAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.7        Rectal Transmucosal Drug Delivery Market

8.4.7.1      Overview

8.4.7.2      Rectal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

8.4.7.3      RECTAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.4.8        Vaginal Transmucosal Drug Delivery Market

8.4.8.1      Overview

8.4.8.2      Vaginal Transmucosal Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

8.4.8.3      VAGINAL DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.5       Topical drug delivery Market

8.5.1        Overview

8.5.2        Topical Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

8.5.3        Semi-solid Topical Drug Delivery Formulations Market

8.5.3.1      Overview

8.5.3.2      Semi-solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)

8.5.3.3      SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.5.4        Liquid Topical Drug Delivery Formulations Market

8.5.4.1      Overview

8.5.4.2      Liquid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)

8.5.4.3      LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.5.5        Solid Topical Drug Delivery Formulations Market

8.5.5.1      Overview

8.5.5.2      Solid Topical Drug Delivery Formulations Market Revenue and Forecast to 2027 (US$ Mn)

8.5.5.3      SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.5.6        Transdermal Patches Market

8.5.6.1      Overview

8.5.6.2      Transdermal Patches Market Revenue and Forecast to 2027 (US$ Mn)

8.5.6.3      TRANSDERMAL PATCHES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.5.7        Transdermal Gels Market

8.5.7.1      Overview

8.5.7.2      Transdermal Gels Market Revenue and Forecast to 2027 (US$ Mn)

8.5.7.3      TRANSDERMAL GELS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.5.8        Others Market

8.5.8.1      Overview

8.5.8.2      Others Market Revenue and Forecast to 2027 (US$ Mn)

8.5.8.3      OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.6       injectable drug delivery Market

8.6.1        Overview

8.6.2        Injectable Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources

8.6.3        Conventional Injection Devices Market

8.6.3.1      Overview

8.6.3.2      Conventional Injection Devices Market Revenue and Forecast to 2027 (US$ Mn)

8.6.3.3      CONVENTIONAL INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.6.4        Self-Injection Devices Market

8.6.4.1      Overview

8.6.4.2      SELF-INJECTION Devices Market Revenue and Forecast to 2027 (US$ Mn)

8.6.4.3      SELF-INJECTION DEVICES MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.6.4.4      Needle Free Injectors Market

8.6.4.4.1       Overview

8.6.4.4.2       Needle Free Injectors Market Revenue and Forecast to 2027 (US$ Mn)

8.6.4.4.3       NEEDLE FREE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.6.4.5      Pen injectors Market

8.6.4.5.1       Overview

8.6.4.5.2       Pen injectors Market Revenue and Forecast to 2027 (US$ Mn)

8.6.4.5.3       PEN INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.6.4.6      Wearable Injectors Market

8.6.4.6.1       Overview

8.6.4.6.2       Wearable Injectors Market Revenue and Forecast to 2027 (US$ Mn)

8.6.4.6.3       WEARABLE INJECTORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.7       Implantable drug delivery Market

8.7.1        Overview

8.7.2        Implantable drug delivery Market Revenue and Forecast to 2027 (US$ Mn)

Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources

8.7.3        Active Implantable Market

8.7.3.1      Overview

8.7.3.2      Active Implantable Market Revenue and Forecast to 2027 (US$ Mn)

8.7.3.3      ACTIVE IMPLANTABLE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.7.4        Passive Implantable Market

8.7.4.1      Overview

8.7.4.2      Passive Implantable Market Revenue and Forecast to 2027 (US$ Mn)

8.7.4.3      Passive Implantable MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.8       ocular drug delivery Market

8.8.1        Overview

8.8.2        Ocular Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

Source: The Insight Partners Analysis, Primary Interviews, Secondary Sources

8.8.3        Eye Drops and Sprays Market

8.8.3.1      Overview

8.8.3.2      Eye Drops and Sprays Market Revenue and Forecast to 2027 (US$ Mn)

8.8.3.3      Eye Drops And Spray MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.8.4        Gels & Ointments Market

8.8.4.1      Overview

8.8.4.2      Gels & Ointments Market Revenue and Forecast to 2027 (US$ Mn)

8.8.4.3      Gels & Ointments MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.8.5        Ocular Inserts Market

8.8.5.1      Overview

8.8.5.2      Ocular Inserts Market Revenue and Forecast to 2027 (US$ Mn)

8.8.5.3      Occular Inserts MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

8.8.6        Drug Coated Contact Lens Market

8.8.6.1      Overview

8.8.6.2      Drug Coated Contact Lens Market Revenue and Forecast to 2027 (US$ Mn)

8.8.6.3      Drug Coated Contact Lens MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)

9.             global drug delivery systems Market analysis– by distribution channel

9.1       overview

9.2       global drug delivery systems MARKET, by distribution channel 2018 & 2027 (%)

9.3       hospital pharmacies market

9.3.1        Overview

9.3.2        Global Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4       retail pharmacies market

9.4.1        Overview

9.4.2        Global Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

9.5       online pharmacies market

9.5.1        Overview

9.5.2        Global Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.          global drug delivery systems Market analysis– by Application

10.1    overview

10.2    global drug delivery systems MARKET, by applicaton 2018 & 2027 (%)

10.3    homecare Settings market

10.3.1     Overview

10.3.2     Global Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)

10.4    hospitals & clinics Market

10.4.1     Overview

10.4.2     Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

10.5    others Market

10.5.1     Overview

10.5.2     Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

11.          Drug delivery systems market REVENUE AND FORECASTS TO 2027 – GeographicAL ANALYSIS

11.1    north america drug delivery market

11.1.1     Overview

11.1.2     North America Drug Delivery Market Revenue And Forecasts to 2027 (US$ Mn)

11.1.3     North America Drug Delivery Market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)

11.1.3.1    North America Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.2    North America Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.3    North America Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.4    North America Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.4.1    North America Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.5    North America Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.6    North America Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.7    North America Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.3.8    North America Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.4     North America Drug delivery market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.1.5     North America Drug delivery market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.1.6     North America Drug delivery Market Revenue And Forecasts to 2027, By Country (%)

11.1.7     US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.1.8     US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.1.8.1    US Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.1    US Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.2    US oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.3    US Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.4    US Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.4.1        US Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.5    US Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.6    US Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.7    US Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.1.8    US Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.8.2    US Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.1.8.3    US Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.1.9     Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.1.10   Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.1.10.1 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.1 Canada Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.2 Canada Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.3 Canada Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.4 Canada Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.5 Canada Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.6 Canada Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.7 Canada Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.8 Canada Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.1.9 Canada Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.10.2 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.1.10.3 Canada Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.1.11   Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.1.12   Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.1.12.1 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.1 Mexico Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.2 Mexico Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.3 Mexico Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.4 Mexico Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.5 Mexico Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.6 Mexico Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.7 Mexico Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.8 Mexico Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.1.9 Mexico Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.1.12.2 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.1.12.3 Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.2    Europe drug delivery systems market

11.2.1     Overview

11.2.2     Europe Drug delivery systems market revenue Overview, by Country (2017) (US$ Mn)

11.2.3     Europe Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.2.4     Europe Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.1    Europe Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.2    Europe oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.3    Europe Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.4    Europe Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.5    Europe Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.6    Europe Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.7    Europe Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.8    Europe Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.4.9    Europe Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.5     Europe Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.2.6     Europe Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.2.7     Europe Drug delivery systems market Revenue and Forecasts to 2027, By Country (%)

11.2.8     Germany Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9     Germany Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.2.9.1    Germany Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.1    Germany Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.2    Germany Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.3    Germany Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.4    Germany Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.4.1        Germany Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.5    Germany Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.6    Germany Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.7    Germany Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.1.8    Germany Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.9.2    Germany Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.2.9.3    Germany Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.2.10   France Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.2.11   France Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.2.11.1 France  Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.1 France Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.2 France Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.3 France Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.4 France Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.5 France Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.6 France Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.7 France Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.8 France Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.1.9 France Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.11.2 France Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.2.11.3 France Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.2.12   UK Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.2.13   UK Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.2.13.1 UK  Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.1 UK Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.2 UK Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.3 UK Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.4 UK Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.5 UK Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.6 UK Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.7 UK Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.8 UK Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.1.9 UK Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.2.13.2 UK Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.2.13.3 UK Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.3    ASIA Pacific DRUG DELIVERY SYSTEMS MARKET

11.3.1     Overview

11.3.2     Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027 (US$ Mn)

11.3.3     Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Route Of Administration (US$ Mn)

11.3.3.1    Asia Pacific Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.3.2    Asia Pacific Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.3.3    Asia Pacific Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.3.4    Asia Pacific Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.3.4.1    Asia Pacific Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.3.5    Asia Pacific Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.3.6    Asia Pacific Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.3.7    Asia Pacific Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.3.8    Asia Pacific Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.4     Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.3.5     Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.3.6     Asia Pacific Drug delivery systems market Revenue and Forecasts to 2027, By Country (%)

11.3.7     China Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.3.8     China Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.3.8.1    China Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.1    China Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.2    China Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.3    China Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.4    China Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.5    China Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.6    China Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.7    China Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.8    China Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.1.9    China Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.8.2    China Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.3.8.3    China Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Source: The Insight Partners

11.3.9     Japan Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.3.10   Japan Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.3.10.1 Japan Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.1 Japan Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.2 Japan Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.3 Japan Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.4 Japan Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.5 Japan Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.6 Japan Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.7 Japan Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.8 Japan Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.1.9 Japan Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.10.2 Japan Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.3.10.3 Japan Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.3.11   India Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.3.12   India Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.3.12.1 India Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.1 India Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.2 India Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.3 India Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.4 India Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.5 India Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.6 India Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.7 India Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.8 India Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.1.9 India Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.3.12.2 India Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.3.12.3 India Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.4    Middle East & Africa Drug delivery systems market

11.4.1     Middle East & Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.4.2     Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.1    Middle East & Africa Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.2    Middle East & Africa oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.3    Middle East & Africa Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.4    Middle East & Africa Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.5    Middle East & Africa Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.6    Middle East & Africa Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.7    Middle East & Africa Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.8    Middle East & Africa Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.2.9    Middle East & Africa Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.3     Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.4.4     Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.4.5     Middle East & Africa Drug delivery systems market Revenue and Forecasts to 2027, By Country (%)

11.4.6     UAE Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.4.7     UAE Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.4.7.1    UAE  Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.1    UAE Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.2    UAE Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.3    UAE Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.4    UAE Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.5    UAE Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.6    UAE Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.7    UAE Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.8    UAE Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.1.9    UAE Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.7.2    UAE Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.4.7.3    UAE Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.4.8     Saudi Arabia Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.4.9     Saudi Arabia Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.4.9.1    SAUDI ARABIA  Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.1    SAUDI ARABIA Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.2    SAUDI ARABIA Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.3    SAUDI ARABIA Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.4    SAUDI ARABIA Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.5    SAUDI ARABIA Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.6    SAUDI ARABIA Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.7    SAUDI ARABIA Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.8    SAUDI ARABIA Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.1.9    SAUDI ARABIA Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.9.2    SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.4.9.3    SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.4.10   South Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.4.11   South Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.4.11.1 SOUTH AFRICA  Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.1 SOUTH AFRICA Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.2 SOUTH AFRICA Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.3 SOUTH AFRICA Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.4 SOUTH AFRICA Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.5 SOUTH AFRICA Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.6 SOUTH AFRICA Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.7 SOUTH AFRICA Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.8 SOUTH AFRICA Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.1.9 SOUTH AFRICA Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.4.11.2 SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.4.11.3 SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.5    SOUTH AND CENTRAL AMERICA DRUG DELIVERY SYSTEMS MARKET

11.5.1     Overview

11.5.2     South and Central America Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.5.3     South and Central America Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.1    South and Central America Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.2    South and Central America oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.3    South and Central America Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.4    South and Central AmericaInjectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.5    South and Central America Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.6    South and Central America Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.7    South and Central America Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.8    South and Central America Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.3.9    South and Central America Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.4     South and Central America Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.5.5     South and Central America Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.5.6     South and Central America Drug delivery systems market Share by Country, 2017 and 2027 (%)

11.5.7     Brazil Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.5.8     Brazil Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

11.5.8.1    Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.1    Brazil Transmucosal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.2    Brazil Oral Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.3    Brazil Pulmonary Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.4    Brazil Injectable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.4.1        Brazil Self-Injection Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.5    Brazil Topical Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.6    Brazil Nasal Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.7    Brazil Implantable Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.1.8    Brazil Ocular Market Revenue And Forecasts to 2027, By Type (US$ Mn)

11.5.8.2    Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Application (US$ Mn)

11.5.8.3    Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

12.          drug delivery systems market – Industry Landscape

12.1    Overview

12.2    Comparative Company Analysis

12.3    Growth Strategies done by the companies in the Market, (%)

12.4    Organic Developments

12.4.1     Overview

12.5    Inorganic developments

12.5.1     Overview

13.          Drug delivery systems market–Key company profiles

13.1    3M

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Financial Overview

13.1.4     Product Portfolio

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    BD

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Financial Overview

13.2.4     Product Portfolio

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Boston Scientific Corporation

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Financial Overview

13.3.4     Product Portfolio

13.3.5     Swot Analysis

13.3.6     Key Developments

13.4    novo nordisk a/s

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Financial Overview

13.4.4     Product Portfolio

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Bausch Health Companies Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Financial Overview

13.5.4     Product Portfolio

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    BAxter International, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Financial Overview

13.6.4     Product Portfolio

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Boehringer Ingelheim International GmbH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Financial Overview

13.7.4     Product Portfolio

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Novartis AG

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Financial Information

13.8.4     Product Portfolio

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    GlaxoSmithKline plc.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Financial Overview

13.9.4     Product Portfolio

13.9.5     Swot Analysis

13.9.6     Key Developments

13.10 Johnson & Johnson Services, Inc.

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Financial Overview

13.10.4   Product Portfolio

13.10.5   Swot Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

 

list of tables

 

TABLE 1.           R&D Investments by major pharmaceutical companies

TABLE 2.           North America Drug delivery market Revenue And Forecasts to 2027, By route of administration (US$ Mn)

TABLE 3.           North America Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 4.           North America oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 5.           North America Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 6.           North America Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 7.           North America Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 8.           North America topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 9.           North America nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 10.        North America Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 11.        North America Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 12.        North America Drug delivery market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 13.        North America Drug delivery market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 14.        US Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 15.        US Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 16.        US oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 17.        US Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 18.        US Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 19.        US Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 20.        US topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 21.        US nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 22.        US Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 23.        US Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 24.        US Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 25.        US Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 26.        Canada Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 27.        Canada Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 28.        Canada oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 29.        Canada Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 30.        Canada Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 31.        Canada Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 32.        Canada topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 33.        Canada nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 34.        Canada Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 35.        Canada Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 36.        Canada Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 37.        Canada Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 38.        Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 39.        Mexico Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 40.        Mexico oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 41.        Mexico Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 42.        Mexico Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 43.        Mexico Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 44.        Mexico topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 45.        Mexico nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 46.        Mexico Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 47.        Mexico Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 48.        Mexico Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 49.        Mexico Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 50.        Europe Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 51.        Europe Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 52.        Europe oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 53.        Europe Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 54.        Europe Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 55.        Europe Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 56.        Europe topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 57.        Europe nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 58.        Europe Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 59.        Europe Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 60.        Europe Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 61.        Europe Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 62.        Germany Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 63.        Germany Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 64.        Germany oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 65.        Germany Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 66.        Germany Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 67.        Germany Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 68.        Germany topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 69.        Germany nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 70.        Germany Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 71.        Germany Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 72.        Germany Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 73.        Germany Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 74.        France Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 75.        France Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 76.        France oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 77.        France Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 78.        France Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 79.        France Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 80.        France topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 81.        France nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 82.        France Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 83.        France Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 84.        France Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 85.        France Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 86.        UK Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 87.        UK Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 88.        UK oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 89.        UK Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 90.        UK Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 91.        UK Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 92.        UK topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 93.        UK nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 94.        UK Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 95.        UK Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 96.        UK Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 97.        UK Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 98.        Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By route of administration (US$ Mn)

TABLE 99.        Asia Pacific Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 100.     Asia Pacific oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 101.     Asia Pacific Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 102.     Asia Pacific Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 103.     Asia Pacific Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 104.     Asia Pacific topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 105.     Asia Pacific nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 106.     Asia Pacific Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 107.     Asia Pacific Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 108.     Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 109.     Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 110.     China Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 111.     China Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 112.     China oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 113.     China Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 114.     China Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 115.     China Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 116.     China topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 117.     China nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 118.     China Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 119.     China Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 120.     China Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 121.     China Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 122.     Japan Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 123.     Japan Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 124.     Japan oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 125.     Japan Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 126.     Japan Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 127.     Japan Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 128.     Japan topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 129.     Japan nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 130.     Japan Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 131.     Japan Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 132.     Japan Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 133.     Japan Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 134.     India Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 135.     India Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 136.     India oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 137.     India Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 138.     India Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 139.     India Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 140.     India topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 141.     India nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 142.     India Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 143.     India Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 144.     India Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 145.     India Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 146.     Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 147.     Middle East & Africa Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 148.     Middle East & Africa oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 149.     Middle East & Africa Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 150.     Middle East & Africa Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 151.     Middle East & Africa Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 152.     Middle East & Africa topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 153.     Middle East & Africa nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 154.     Middle East & Africa Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 155.     Middle East & Africa Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 156.     Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 157.     Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 158.     UAE Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 159.     UAE Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 160.     UAE oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 161.     UAE Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 162.     UAE Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 163.     UAE Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 164.     UAE topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 165.     UAE nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 166.     UAE Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 167.     UAE Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 168.     UAE Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 169.     UAE Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 170.     SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 171.     SAUDI ARABIA Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 172.     SAUDI ARABIA oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 173.     SAUDI ARABIA Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 174.     SAUDI ARABIA Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 175.     SAUDI ARABIA Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 176.     SAUDI ARABIA topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 177.     SAUDI ARABIA nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 178.     SAUDI ARABIA Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 179.     SAUDI ARABIA Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 180.     SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 181.     SAUDI ARABIA Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 182.     SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 183.     SOUTH AFRICA Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 184.     SOUTH AFRICA oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 185.     SOUTH AFRICA Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 186.     SOUTH AFRICA Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 187.     SOUTH AFRICA Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 188.     SOUTH AFRICA topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 189.     SOUTH AFRICA nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 190.     SOUTH AFRICA Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 191.     SOUTH AFRICA Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 192.     SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 193.     SOUTH AFRICA Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 194.     South and Central AmericaDrug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 195.     South and Central AmericaTransmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 196.     South and Central America oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 197.     South and Central America Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 198.     South and Central AmericaInjectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 199.     South and Central AmericaSelf-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 200.     South and Central Americatopical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 201.     South and Central America nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 202.     South and Central America Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 203.     South and Central AmericaOcular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 204.     South and Central AmericaDrug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 205.     South and Central America Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 206.     Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 207.     Brazil Transmucosal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 208.     Brazil oral market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 209.     Brazil Pulmonary market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 210.     Brazil Injectable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 211.     Brazil Self-Injection Devices market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 212.     Brazil topical market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 213.     Brazil nasal market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 214.     Brazil Implantable market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 215.     Brazil Ocular market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 216.     Brazil Drug delivery systems market Revenue And Forecasts to 2027, By application (US$ Mn)

TABLE 217.     Brazil Drug delivery systems market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 218.     Organic Developments Done By Companies

TABLE 219.     Inorganic developments done by Companies

TABLE 220.     Glossary of Terms, Drug delivery systems market

 

list of figures

FIGURE 1.        drug delivery systems market Segmentation

FIGURE 2.        drug delivery systems Segmentation, by region

FIGURE 3.        Asia PAcific Drug delivery systems market, Revenue (US$ Mn), 2018 & 2027

FIGURE 4.        Global drug delivery systems market By Product, Market Share (%), 2018

FIGURE 5.        Global Drug delivery systems market By application, Market Share (%), 2018

FIGURE 6.        Global Drug delivery systems market By distribution channel, Market Share (%), 2018

FIGURE 7.        North America PEST Analysis

FIGURE 8.        Europe PEST Analysis

FIGURE 9.        Asia Pacific PEST Analysis

FIGURE 10.     Middle East & Africa PEST Analysis

FIGURE 11.     South & Central America PEST Analysis

FIGURE 12.     drug delivery systems market impact analysis of driver and restraints

FIGURE 13.     global drug delivery systems market – Revenue Forecasts and Analysis –2018- 2027

FIGURE 14.     global drug delivery systems market – by geography Forecasts and Analysis – 2018- 2027

FIGURE 15.     Route of administration MARKET Analysis and Forecasts 2018 and 2027 (%)

FIGURE 16.     Oral Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 17.     transmucosal Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.     topical Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.     injectable Drug Delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 20.     Implantable drug delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21.     Ocular drug delivery Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 22.     global drug delivery systems Market breakdown, by end user 2018 & 2027 (%)

FIGURE 23.     Global HOSPITAL PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24.     Global RETAIL PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25.     Global online PHARMACIES Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 26.     global drug delivery systems Market breakdown, by application 2018 & 2027 (%)

FIGURE 27.     Global Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 28.     Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 29.     Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30.     North America Drug delivery market revenue Overview, by Country (2018) (us $ mn)

FIGURE 31.     North America Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 32.     North America Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)

FIGURE 33.     US Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 34.     Canada Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 35.     Mexico Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 36.     Europe Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 37.     Europe Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)

FIGURE 38.     Germany Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 39.     France Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 40.     UK Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 41.     Asia Pacific Drug delivery systems market revenue Overview, by Country (2018) (us $ mn)

FIGURE 42.     Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 43.     Asia Pacific Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)

FIGURE 44.     China Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 45.     Japan Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46.     India Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 47.     Middle East & Africa drug delivery systems market REVENUE, by Country, 2018 (US$ MN)

FIGURE 48.     Middle East & Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 49.     Middle East & Africa Drug delivery systems market Revenue And Forecasts to 2027, By Country (%)

FIGURE 50.     UAE Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 51.     Saudi Arabia Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52.     South Africa Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 53.     South and Central America drug delivery systems market REVENUE, by Country, 2017 (US$ MN)

FIGURE 54.     South and Central America Drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 55.     South and Central America Drug delivery systems market SHARE BY COUNTRY, 2017 AND 2027 (%)

FIGURE 56.     Brazil drug delivery systems market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 57.     Comparative Company Analysis

FIGURE 58.     Growth Strategies done by the companies in the Market, (%)

The List of Companies

  1. BD (Becton Dickinson & Company)
  2. Boston Scientific Corporation
  3. Novo Nordisk A/S
  4. Bausch Health Companies Inc.
  5. Baxter International, Inc.
  6. Boehringer Ingelheim
  7. Novartis AG
  8. GlaxoSmithKline plc.
  9. Johnson & Johnson Services, Inc.
  10. Terumo Corporation

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the drug delivery systems market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global drug delivery systems market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.